Rare Community Profiles: Probably Genetic Offers No-Cost Genetic Testing for Rare Diseases: A Conversation with CEO Lukas Lange
source: shutterstock.com

Rare Community Profiles: Probably Genetic Offers No-Cost Genetic Testing for Rare Diseases: A Conversation with CEO Lukas Lange

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Probably Genetic Offers No-Cost Genetic Testing for Rare Diseases: A Conversation with CEO Lukas Lange
NICE Guidance Recommends Upstaza for AADC Deficiency
source: shutterstock

NICE Guidance Recommends Upstaza for AADC Deficiency

  In November 2022, the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) approved Upstaza (eladocagene exuparvovec) for the treatment of aromatic L-amino acid decarboxylase (AADC) deficiency. The product, which…

Continue Reading NICE Guidance Recommends Upstaza for AADC Deficiency

PTC-AADC Shows Benefits for Patients with AADC Deficiency, Data Shows

Recently, biopharmaceutical company PTC Therapeutics, Inc. performed a five-year data analysis to evaluate the continued safety, efficacy, and tolerability of PTC-AADC. The company developed this novel gene therapy to improve…

Continue Reading PTC-AADC Shows Benefits for Patients with AADC Deficiency, Data Shows
Study Illuminates Impact of Aromatic L-Amino Acid Decarboxylase Deficiency on Caregivers
source: pixabay.com

Study Illuminates Impact of Aromatic L-Amino Acid Decarboxylase Deficiency on Caregivers

PTC Therapeutics has just announced data from the very first study which examined how taking care of a child diagnosed with aromatic L-amino acid decarboxylase (AADC) deficiency can impact caregivers.…

Continue Reading Study Illuminates Impact of Aromatic L-Amino Acid Decarboxylase Deficiency on Caregivers
Expanded Partnership Will Offer Genetic Testing for AADC Deficiency
https://pixabay.com/en/baby-child-cute-doll-expression-17366/

Expanded Partnership Will Offer Genetic Testing for AADC Deficiency

  As of the end of August 2020, CENTOGENE has collaborated with more than 40 pharmaceutical partners to develop solutions for patients with rare diseases. In a press release from…

Continue Reading Expanded Partnership Will Offer Genetic Testing for AADC Deficiency
Dantrolene Effective for Muscle Problems in AADC Deficiency Children: Case Study
source: pixabay.com

Dantrolene Effective for Muscle Problems in AADC Deficiency Children: Case Study

By Jodee Redmond from In The Cloud Copy The results of a case study have found that dantrolene can be used to treat involuntary muscle contractions (dystonia) in children with…

Continue Reading Dantrolene Effective for Muscle Problems in AADC Deficiency Children: Case Study